If you’d invested in: Persimmon and Centrica
Persimmon is the UK’s second-largest housebuilder. In November, it said the total sales rate per site for the third quarter was in line with the same period last year.
If only...
Persimmon (LSE: PSN) is the UK's second-largest housebuilder. In November, it said the total sales rate per site for the third quarter was in line with the same period last year, although it reported £909m of forward sales reserved beyond 2017, an increase of 10% on the same period last year.
The government's help-to-buy equity loan scheme, which allows people to buy newly built homes with deposits of only 5%, has been used in more than half of the firm's sales.
Be glad you didn't
Centrica (LSE: CNA) provides energy for homes and businesses. Its shares have fallen by 57% over the past four years. In October, it announced a restructuring the management plans to reallocate £1.5bn of resources from asset businesses to customer-facing businesses by 2020. In November, it also acquired REstore, a firm that manages electricity demand for heavy energy users, for £62m.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alice grew up in Stockholm and studied at the University of the Arts London, where she gained a first-class BA in Journalism. She has written for several publications in Stockholm and London, and joined MoneyWeek in 2017.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Persimmon yields 13.8%, but can you trust it to deliver?
Tips With a dividend yield of 13.8%, Persimmon looks like a highly attractive prospect for income investors. But that sort of yield can also indicate a company in distress. Rupert Hargreaves looks at the numbers to find out if it's sustainable.
By Rupert Hargreaves Published
-
Despite surging profits investors should avoid Centrica shares
Tips Profits in the energy sector are booming but Centrica shares are struggling. Rupert Hargreaves explains why he’d avoid the stock.
By Rupert Hargreaves Last updated
-
Centrica: the only way is up
News Centrica's share price has fallen by nearly 90% over the past few years. New finance director Chris O’Shea will hope to reverse that.
By Dr Matthew Partridge Published
-
Will Centrica slash dividends?
Features Finances are tight and payouts are under threat. The gas supplier’s new boss faces some tricky decisions, says Alice Gråhns.
By Alice Gråhns Published
-
Is it time to buy Centrica for its huge dividend?
Features Shares in Centrica, owner of British Gas, come with a dividend yield of 8% after the share price fell dramatically last week. So should you buy in?
By John Stepek Published
-
Should you buy housebuilders?
Features House builders have seen their shares hammered since the Brexit vote. Is there further to fall – or is this a buying opportunity? Sarah Moore investigates.
By Sarah Moore Published
-
FTSE 100 ahead as eurozone succumbs to deflation
Market Reports Falling prices in the eurozone have heaped yet more pressure on central bank boss Mario Draghi to turn on the money taps.
By Kam Patel Published
-
Shares in focus: Centrica’s comeback trail
Features Utility company Centrica has had a rough ride. But with the shares offering a decent dividend yield, should you still buy in? Phil Oakley investigates.
By Phil Oakley Published